1. Home
  2. FORTY vs VCEL Comparison

FORTY vs VCEL Comparison

Compare FORTY & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FORTY

Formula Systems (1985) Ltd.

HOLD

Current Price

$117.51

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$43.00

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORTY
VCEL
Founded
1985
1989
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
1998
1996

Fundamental Metrics

Financial Performance
Metric
FORTY
VCEL
Price
$117.51
$43.00
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$57.75
AVG Volume (30 Days)
406.0
461.2K
Earning Date
05-21-2026
05-07-2026
Dividend Yield
1.32%
N/A
EPS Growth
N/A
60.00
EPS
N/A
N/A
Revenue
N/A
$276,259,000.00
Revenue This Year
N/A
$19.40
Revenue Next Year
N/A
$18.24
P/E Ratio
$36.65
N/A
Revenue Growth
N/A
16.45
52 Week Low
$102.01
$28.95
52 Week High
$190.56
$49.32

Technical Indicators

Market Signals
Indicator
FORTY
VCEL
Relative Strength Index (RSI) 54.31 42.23
Support Level $115.00 $32.44
Resistance Level $119.68 $49.04
Average True Range (ATR) 0.45 1.43
MACD 1.61 -0.35
Stochastic Oscillator 78.82 24.30

Price Performance

Historical Comparison
FORTY
VCEL

About FORTY Formula Systems (1985) Ltd.

Formula Systems (1985) Ltd is an information technology company that is principally engaged through its directly and indirectly held investees in providing software consulting services, selling and marketing computer-based business solutions and hardware products from a wide range of domestic and international manufacturers, as well as developing proprietary software solutions. It delivers solutions in Israel and in numerous countries to customers with complex IT services needs. It designs and implements IT solutions and software systems that improve the productivity of customers' existing IT assets, enable them to effectively manage their operations and reduce their business risks in the face of changing business environments.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: